Gadobenate dimeglumine and Alcohol/Food Interactions
There is 1 alcohol/food/lifestyle interaction with gadobenate dimeglumine.
Gadobenate Dimeglumine High Blood Pressure (Hypertension)
Major Potential Hazard, Moderate plausibility
gadolinium-based contrast agents - renal impairment
Gadolinium-based contrast agents (GBCAs) increase the risk for nephrogenic systemic fibrosis (NSF) among patients with impaired elimination of the drugs. Gadobenate ion is eliminated predominately via the kidneys. The risk for NSF appears highest among patients with chronic, severe kidney disease (GFR <30 mL/min/1.73m2), or acute kidney injury. It is recommended to avoid the use of GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other processes. NSF may result in fatal or debilitating systemic fibrosis affecting the skin, muscle and internal organs. Consider screening patients for acute kidney injury and other conditions that may reduce renal function and for patients at risk for chronically reduced renal function (e.g., age > 60 years, hypertension or diabetes), estimate the glomerular filtration rate (GFR) through laboratory testing. For patients receiving hemodialysis, physicians may consider the prompt initiation of hemodialysis following the administration of a GBCA to enhance the contrast agent's elimination. The usefulness of hemodialysis in the prevention of NSF is unknown.
Switch to professional interaction data
Gadobenate dimeglumine drug interactions
There are 55 drug interactions with gadobenate dimeglumine.
Gadobenate dimeglumine disease interactions
There are 5 disease interactions with gadobenate dimeglumine which include:
More about gadobenate dimeglumine
- gadobenate dimeglumine consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: magnetic resonance imaging contrast media
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Magnevist
Magnevist (gadopentetate dimeglumine) is a contrast agent used to help diagnose certain disorders ...
Gadavist
Gadavist (gadobutrol) is a contrast agent used in MRI's to help diagnose certain disorders of the ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Dotarem
Dotarem (gadoterate meglumine) is a gadolinium-based contrast agent used in magnetic resonance ...
Omniscan
Omniscan is used for CNS Magnetic Resonance Imaging, vascular magnetic resonance imaging
Multihance
Multihance is used for CNS Magnetic Resonance Imaging, magnetic resonance angiography
Vasovist
Vasovist is used to help diagnose certain disorders of the heart and blood vessels. Learn about ...
Gadofosveset trisodium
Gadofosveset trisodium systemic is used for magnetic resonance angiography
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.